François Le Loarer is an expert in Oncology at Institut Bergonié (France). As of July 2026, ScienceLeadR ranks François Le Loarer in the top 1% of experts worldwide for Sarcoma. François Le Loarer has authored 218 publications, the most recent in 2026, and is an investigator in 6 clinical trials. SLR score: 748 (community average: 125). How the SLR is computed.

LeadR Profile

François Le Loarer Institut Bergonié France
748 ScienceLeadR Reputation 748
Network Map

Oncology

Subspecialties: Surgery - Genetics - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2014 - 2026

Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 218

Citations

Citations: 6 243 1st author: 17 Last author: 28 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
First Report of Metastatic Atypical Spindle Cell/Pleomorphic Lipomatous Tumor (ASPLT) With Sarcomatous Transformation.
PMID 42526081 — cells, neoplasms, pathology
Mod Pathol20260
MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa.
PMID 42331846 — genes, microscopy, electron, scanning transmission, perivascular epithelioid cell neoplasms, neoplasms, classification, therapeutics, mutation
Nat Commun20260
Economic evaluation of adjuvant chemotherapy for non-metastatic sarcoma using the real-world data from the French nationwide DEEPSARC study.
PMID 42334926 — neoplasms, drug therapy, sarcoma, chemotherapy, adjuvant, chemotherapy
J Med Econ20261
Clinicopathological, Molecular and DNA Methylation Analysis of Ossifying Fibromyxoid Tumors Delineates the ZC3H7B::BCOR Subset as a Distinct Entity.
PMID 42302912 — genes, neoplasms, pathology, dna methylation, dna
Mod Pathol20260
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.
PMID 42291149 — registries, cohort studies, drug therapy, sarcoma, chemotherapy, adjuvant, work, therapeutics, tissues, aids-related complex, chemotherapy
EClinicalMedicine20263

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 4
N/A 2

By status:

Completed 5
Active not recruiting 1

By type:

Interventional 5
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 2
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map